CCL: Structure-Based Drug Design Conference - Register by Friday!



 Sent to CCL by: "James G Prudhomme" [jprudhomme.:.healthtech.com]
 ***Advanced Registration Discounts End May 1st***
 CHIs Structure-Based Drug Design: Sophisticated Approaches to Drug Discovery
 June 4-5, 2009
 Royal Sonesta Hotel - Cambridge, Massachusetts
 www.healthtech.com/SBD
 Topics of discussion include:
      - Target Structure-Guided Drug Discovery
      - Feeding SBDD with Biochemical and Biophysical Information
      - Ligand-Based Predictions Applied to Drug Design
      - SBDD and Computational Chemistry Methods: A Marriage of Innovation
      - SBDD of Pharmacological Chaperons
 Distinguished Faculty:
 Alex Aronov, Ph.D., Vertex Pharmaceuticals, Inc.
 Xavier Barril, Ph.D. , ICREA Research Universitat de Barcelona
 Alex Burgin, Ph.D., deCODE Biostructures
 Miles Congreve, Ph.D., Heptares Therapeutics Ltd.
 Jos Duca, Ph.D., Schering Plough Research Institute
 Stefan Geschwindner, Ph.D., AstraZeneca R&D Mlndal
 Ajay N. Jain, Ph.D., University of California, San Francisco
 Paul Labute, Ph.D., Computing Group (CCG)
 Dr. Richard J. Law, Evotec AG
 Brian B. Masek, Ph.D., Tripos International
 Mark Murcko, Ph.D., Vertex Pharmaceuticals, Inc.
 Sander Nabuurs, Ph.D., Radboud University Nijmegen
 Enrico O. Purisima, Ph.D., National Research Council of Canada
 Dagmar Ringe, Ph.D., Brandeis University
 Suo-Bao Rong, Ph.D., Pfizer Global R&D
 Tomi Sawyer, Ph.D., AILERON Therapeutics; Editor-in-Chief, Chemical Biology
 & Drug Design
 Andrew D. Scott, Ph.D., Pfizer Global Research and Development
 Suresh Singh, Ph.D., Vitae Pharmaceuticals
 Raymond C. Stevens, Scripps Research Institute
 Gergely Toth, Ph.D., Elan Pharmaceuticals
 Marcel Verdonk, Ph.D., Astex Therapeutics, Ltd.
 Markus Wagener, Ph.D., Schering-Plough Research Institute
 W. Patrick Walters, Ph.D., Vertex Pharmaceuticals, Inc.
 Plus! Pre-Conference Workshop, Wednesday, June 3
 Designing Kinase Inhibitors*
 Topics Discussed:
 - Challenges of Crystal Structures
 - X-Ray Crystallography
 - Target Immobilized NMR Screening
 *Separate registration is required.
 Arrive early to attend...
 Protein Kinase Targets Conference
 June 1-3
 Interested in Presenting a Poster?
 CHI welcomes you to share your research by displaying a poster in front of an
 international delegation.
 Poster abstracts are due May 7, 2009.
 Interested in Sponsorships and Exhibit Opportunities?
 Contact:
 Katelin Fitzgerald
 Manager, Business Development
 Tel: 781-972-5458
 E-mail: kfitzgerald#%#healthtech.com
 Special Pricing is Available to Attend Both the Structure-Based Drug Design and
 Protein Kinase Conferences.
 Learn more , register and submit a poster abstract at www.healthtech.com/SBD
 Otherwise, call CHI at 781-972-5400.